Considering the important role of sialylation in dictating the rate of prion replication and their fate in an organism, manipulation of the sialylation status of PrPScvia altering the steady-state sialylation of its precursor PrPC might offer a novel strategy for developing therapeutic intervention against prion diseases. The gene discussed is PRNP; the disease is prion disease.